Skip to content
“There will be more innovation in health care over the next ten years than in the past century,” Joaquin Duato said in his first […]
New Johnson & Johnson CEO predicts decade of innovation in health care Read More »
Researchers are just beginning work on seeking drugs to treat long COVID, also known as post-acute sequelae of COVID-19, which is described as COVID
The search is on for drugs to treat long COVID Read More »
Cement and steel hold up the construction industry and steel also drives automotive manufacturing, so these raw materials have a big impact on the
Biotech can contribute to the net zero agenda for cement and steel Read More »
Vaccine maker Moderna announced last week that a clinical trial showed their COVID-19 shot is safe and effective for children under age 6, and
Moderna seeks approval of COVID-19 shot for children under six Read More »
If nothing changes regarding antimicrobial resistance, “10 million people worldwide could die of drug-resistant infections annually by 2050–surpassing cancer as a leading cause of
MEDPAGE opinion: Superbugs are getting stronger Read More »
Psychological stress affects a wide range of brain activities and increases the likelihood of numerous mental and physical diseases, according to the American Psychological
Stress: Biotech offers a new approach to solving an old problem Read More »
The “brain fog” that sometimes follows a COVID-19 infection has similarities with “chemo brain,” which can affect people undergoing chemotherapy, as well as other
‘Chemo brain’ clues may explain long COVID brain fog Read More »
High school students in Massachusetts will receive training for biomanufacturing careers and connect with local biotech industries through “Regional Partnerships for Training the Biomanufacturing
New effort trains high schoolers for future biomanufacturing workforce Read More »
The U.S. Food and Drug Administration (FDA) announced Tuesday that it has authorized a “second booster dose of either the Pfizer-BioNTech or the Moderna
FDA approves second mRNA boosters for those over 50 and immunocompromised Read More »
The pharmaceutical industry can do more to address serious mental illness (SMIs), and policy changes can encourage greater drug development in this area, according
Study: Incentivize drug development for serious mental illness Read More »
